Abolfazl Olyaei | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Best Researcher Award

Abolfazl Olyaei
Imam Khomeini International University Faculty of Science, Iran
Abolfazl Olyaei
Affiliation Imam Khomeini International University Faculty of Science
Country Iran
Scopus ID 14009290900
Documents 94
Citations 1,047
h-index 18
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Forensic Scientist Awards
ORCID 0000-0003-2976-9481

The Best Researcher Award recognizes sustained scholarly achievement and measurable scientific impact within a specialized discipline. This article summarizes the academic profile of Abolfazl Olyaei, whose research activities focus on heterocyclic chemistry, green synthetic methodologies, medicinal chemistry, and pharmaceutical sciences. The information presented is based on publicly available scholarly records, publication metadata, citation indicators, and institutional affiliations.[1]

Abstract

Abolfazl Olyaei has established a consistent research portfolio in synthetic organic chemistry with emphasis on environmentally friendly reaction pathways, heterocyclic compounds, and biologically active molecular frameworks. His publication record demonstrates continuing contributions toward sustainable synthetic methodologies and pharmaceutical chemistry, supported by strong citation performance and international journal publications.[2]

Keywords

Green Chemistry, Heterocyclic Synthesis, Pharmaceutical Science, Organic Chemistry, Medicinal Chemistry, Catalysis, Sustainable Synthesis, Toxicology.

Introduction

Modern pharmaceutical research increasingly emphasizes sustainable chemical synthesis and efficient production of biologically relevant compounds. Dr. Olyaei’s investigations contribute to these objectives by exploring one-pot multicomponent reactions, environmentally benign solvents, and innovative heterocyclic scaffolds applicable to medicinal chemistry.[3]

Research Profile

According to indexed scholarly databases, the researcher has produced 94 publications with more than one thousand citations and an h-index of 18. His academic work spans pharmacology, toxicology, pharmaceutical science, and advanced organic synthesis. Collaborative publications appear in internationally recognized journals including RSC Advances and ChemistrySelect.[1]

Research Contributions

  • Development of green multicomponent synthetic methodologies.
  • Investigation of heterocyclic compounds with pharmaceutical relevance.
  • Promotion of aqueous and environmentally friendly reaction media.
  • Review articles summarizing biologically active molecular frameworks.

Publications

  • Aqueous glyoxal: a versatile synthon in heterocyclic synthesis. RSC Advances (2026).
  • Regioselective green synthesis of indole-substituted benzo[f]chromenes. RSC Advances (2026).
  • Sequential Tandem Four-Component Reaction. ChemistrySelect (2025).
  • Review on synthesis of furonaphthoquinones. RSC Advances (2025).
  • Acid-Mediated One-Pot Three-Component Tandem Cyclization. ChemistrySelect (2024).

Research Impact

The citation profile and publication output indicate sustained scholarly influence in synthetic and medicinal chemistry. Research themes emphasize reproducibility, environmentally responsible synthesis, and development of biologically relevant compounds, reflecting continued engagement with internationally recognized scientific challenges.[4]

Award Suitability

Based on documented publication productivity, citation performance, peer-reviewed contributions, and relevance to pharmaceutical and forensic sciences, the academic profile demonstrates characteristics commonly considered during international research award evaluations. This assessment reflects publicly available scholarly evidence rather than endorsement.[5]

Conclusion

Abolfazl Olyaei has developed a noteworthy academic record through sustained publication, interdisciplinary collaboration, and contributions to green synthetic chemistry. His research continues to support advances in pharmaceutical science and heterocyclic chemistry while maintaining international scholarly visibility through indexed publications and measurable citation impact.

External Links

References

  1. Elsevier. Scopus Author Details: Abolfazl Olyaei, Author ID 14009290900.
    https://www.scopus.com/authid/detail.uri?authorId=14009290900
  2. ORCID. Researcher Profile.
    https://orcid.org/0000-0003-2976-9481
  3. RSC Advances. Aqueous glyoxal: a versatile synthon in heterocyclic synthesis.
    https://doi.org/10.1039/D5RA08496B
  4. ChemistrySelect. Sequential Tandem Four-Component Reaction.
    https://doi.org/10.1002/slct.202505685
  5. International Forensic Scientist Awards. Official Award Website.
    forensicscientist.org

Leng Chee Chang | Pharmacology | Research Excellence Award

Prof. Dr. Leng Chee Chang | Pharmacology | Research Excellence Award

University of Hawaii at Hilo | United States

Prof. Dr. Leng Chee Chang is a natural products chemist whose work focuses on the isolation, characterization, and biological evaluation of bioactive compounds from medicinal plants, marine algae, and microbes with applications in cancer chemoprevention, chemotherapeutics, and antimicrobial discovery. According to Scopus-indexed records, she has authored 73 publications, which have been cited 2,567 times, reflecting a substantial global research impact. Her h-index of 28 highlights consistent scholarly influence and sustained citation performance across her body of work. Dr. Chang’s research has appeared in high-impact journals such as Organic Letters, Journal of Natural Products, Molecules, and ACS Omega, and encompasses multidisciplinary collaborations in pharmacognosy, medicinal chemistry, and pharmacology. Her work has contributed to the discovery of novel natural products with therapeutic potential.

                            Citation Metrics (Scopus)

3000

2500

2000

1500

1000

500

0

 

Citations
2567
Documents
73
h-index
28

Citations

Documents

h-index

View Scopus Profile

Featured Publications


A New Trichlorinated Xanthone and Compounds Isolated from Cladonia skottsbergii with Antimicrobial Properties

– Rositzki MJ, Raksat A, Simmons CJ, Smith C, Reverend Danette V. Choi, Wongwiwatthananukit S, Chang LC · Pharmaceuticals, 2026


Bioactive Constituents from the Edible Seaweed Halymenia hawaiiana (Rhodophyta)

– Raksat A, Atanu MSH, McDermimid KJ, Wall MW, Chang BL, Wongwiwatthananukit S, Chang LC · Pharmaceutical Biology, 2025


Bioactive Compounds from Dodonaea viscosa Flowers: Potent Antibacterial and Antiproliferative Effects in Breast Cancer Cells

– Raksat A, Yee D, Gi YJ, Wongwiwatthananukit S, Chang LK, Kaawaloa P, Wall MW, Chang LC · Molecules, 2025 (IF 4.2)


Biologically Active Withanolides from Physalis peruviana L.

– Sang-Ngern M, Fukuchi A, Kondratyuk TP, Park E-J, Simmons CJ, Wall MW, Lorch SE, Pezzuto JM, Chang LC · Pharmaceutical Biology, 2025


Vernonolide A, a Sesquiterpene Lactone with a Unique Carbon Skeleton from Vernonia cinerea

– Zhang M, Kondratyuk TP, Cao S, Li M, Songsak T, Wongwiwatthananukit S, Cai Y-S, Chang LC · Organic Letters, 2025 (IF 4.9)

 

Prabhat Singh | Pharmacology | Excellence in Research

Dr. Prabhat Singh | Neuroscience | Excellence in Research

Faculty of Pharmacy, Swami Vivekanand Subharti University | India

Dr. Prabhat Singh, a seasoned academic and researcher in the field of Pharmacology, currently serves as an Associate Professor at Kharvel Subharti College of Pharmacy, Swami Vivekanand Subharti University, Meerut. Born on July 8, 1988, Dr. Singh holds a B. Pharm., M. Pharm. (Pharmacology), and a Ph.D. His passion lies in advancing pharmaceutical education and scientific R&D. His academic dedication and research acumen have established him as a prominent figure in neuropharmacological research.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

Dr. Prabhat Singh demonstrates a consistent and impactful research trajectory in the field of Neuropharmacology, Vascular Dementia, and Physiological Brain Conditioning. With over 22 peer-reviewed publications, several in high-impact journals such as Neurochemical Research, Current Neurovascular Research, and Central Nervous System Agents in Medicinal Chemistry, his work reflects both depth and innovation.

  • He has published research with a total international impact factor exceeding 31.8, an h-index of 9, and over 300 citations, highlighting growing academic recognition.

  • His exploration of novel pharmacological targets in ischemia-reperfusion brain injury and morphine withdrawal syndromes represents translational value in therapeutic strategies.

  • Dr. Singh has contributed significantly to scholarly literature through book publications (4 authored books), book chapters (3 in Nova Science Publishers, USA), and 6 IPRs on innovative healthcare technologies, including AI-powered medication systems and neurodegenerative disease detection devices.

  • As a Ph.D. supervisor to six scholars and mentor to eight M.Pharm students, he has actively nurtured the next generation of pharmaceutical researchers.

🎓 Education

Dr. Singh completed his Ph.D. in Pharmacology from Dr. APJ Abdul Kalam Technical University, Lucknow in 2022. He earned his M. Pharm. from Mahamaya Technical University, Noida with an impressive 81.78% in 2013 and his B. Pharm. from Uttar Pradesh Technical University in 2011 with 73.19%. His foundational education was completed under the Uttar Pradesh Board, achieving consistent academic performance. He is also a GPAT qualifier (2011) and actively contributes to university committees.

👨‍🏫 Experience

Dr. Singh has over a decade of teaching experience. Since February 2023, he has been working as an Associate Professor at Kharvel Subharti College of Pharmacy. Previously, he served as Assistant Professor at the same institution from 2016 to 2023 and at Kalka Institute for Research and Advanced Studies from 2013 to 2016. Additionally, he has industrial experience as a Product Sales Representative with Dr. Reddy’s Laboratories. He has guided 08 M. Pharm theses and is currently supervising 06 Ph.D. scholars.

🔬 Research Interests On Pharmacology

Dr. Singh’s research interests are deeply rooted in Neuropharmacology, with specific focus on vascular dementia, neurotoxicity, and physiological brain conditioning. His doctoral research involved novel pharmacological interventions during experimental ischemia-reperfusion brain injury. His work integrates behavioral neuroscience and biochemical analysis to explore therapeutic pathways in brain disorders.

🏆 Awards & Achievements

Dr. Singh is a committed academic with a strong track record of publication and intellectual property. He has authored four books, contributed to multiple book chapters published by Nova Science Publishers, and published six IPRs including innovations in AI-based medication systems and neurodegenerative disease detection devices. His cumulative journal impact factor exceeds 31.8, with an h-index of 9 and over 300 citations.

📚 Publications

  • Neuroprotective effects of agomelatine and vinpocetine against chronic cerebral hypoperfusion induced vascular dementia
    Authors: S Gupta, P Singh, B Mohan Sharma, B Sharma
    Year: 2015
    Citations: 73

  • Melatonin receptor and KATP channel modulation in experimental vascular dementia
    Authors: P Singh, S Gupta, B Sharma
    Year: 2015
    Citations: 45

  • Modulation of transient receptor potential vanilloid subtype 1 (TRPV1) and norepinephrine transporters (NET) protect against oxidative stress, cellular injury, and vascular …
    Authors: S Gupta, B Sharma, P Singh, B Mohan Sharma
    Year: 2014
    Citations: 40

  • Neuroprotective effects of nicorandil in chronic cerebral hypoperfusion-induced vascular dementia
    Authors: S Gupta, P Singh, B Sharma
    Year: 2016
    Citations: 26

  • Reversal in cognition impairments, cholinergic dysfunction, and cerebral oxidative stress through the modulation of ryanodine receptors (RyRs) and cysteinyl leukotriene-1 …
    Authors: P Singh, B Sharma
    Year: 2016
    Citations: 25

  • Selective serotonin-norepinephrine re-uptake inhibition limits renovascular-hypertension induced cognitive impairment, endothelial dysfunction, and oxidative stress injury
    Authors: P Singh, B Sharma
    Year: 2016
    Citations: 23

  • In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator
    Authors: P Singh, B Sharma, S Gupta, BM Sharma
    Year: 2015
    Citations: 22

  • Antiepileptic activity of aqueous extract of Tricosanthes dioica Roxb
    Authors: SG Prabhat Singh, Vipin K Garg, Pramod K Sharma
    Year: 2012
    Citations: 13

  • Plant bioactive compounds and their mechanistic approaches in the treatment of diabetes: a review
    Authors: Anshika, RK Pandey, L Singh, S Kumar, P Singh, M Pathak, S Jain
    Year: 2022
    Citations: 12

  • Antagonism of endothelin (ETA and ETB) receptors during renovascular hypertension-induced vascular dementia improves cognition
    Authors: P Singh, S Gupta, B Sharma
    Year: 2016
    Citations: 12

🧩 Conclusion

Dr. Prabhat Singh exemplifies academic excellence and research innovation in pharmacological sciences. With deep engagement in neuropharmacology, substantial teaching contributions, groundbreaking IPRs, and impactful publications, he continues to push the frontiers of pharmaceutical research and education. His commitment to scientific inquiry and student mentorship makes him a highly deserving candidate for this prestigious research award.